The Next World War – Defeating Diabetes

//The Next World War – Defeating Diabetes

The Next World War – Defeating Diabetes

Here’s a shocking fact: 346 million people worldwide have diabetes. More than 90 percent of them – including an increasing number of children—have type 2 diabetes, putting them at greater risk for heart disease, stroke, blindness, neuropathy, kidney failure, and death.1 The rising obesity rate – more than doubled since 1980 – is driving much of this global epidemic.

Bioscience researchers around the world are waging war on diabetes, and MPI Research is providing key weaponry: fast, accurate, and innovative preclinical models to help advance the most promising treatments.

MPI Research stands with you on the battlefield against this deadly disease – and like you, we will never surrender.

Diabetes Models from MPI Research

Type 1 diabetes

  • Streptozotocin-induced

Type 2 diabetes

  • Rat and mouse, diet-induced, and genetic models available
  • Body weights, glucose, and insulin levels
  • Glucose and insulin tolerance tests
  • Gene expression analysis of relevant metabolic pathways
  • Variety of additional biomarkers available

Obesity

  • Diet-induced and genetic models
  • Weight gain and prevention studies

Hyperlipidemia

  • Rodent models: fructose-induced hypertriglyceridemia, high fat, and high cholesterol diets
  • Body weights, complete lipid profiling, glucose, and insulin levels
  • Histochemical and immunohistochemical staining for lipids, fibrosis, and inflammatory cells
  • Arterial plaque formation and quantitation
By |2017-07-04T10:29:13+00:00June 13th, 2012|News|Comments Off on The Next World War – Defeating Diabetes

About the Author:

MPI Research, with global headquarters in Mattawan, Mich., provides safety evaluation, discovery, bioanalytical and analytical services to the biopharmaceutical, medical device, animal health, and chemical industries. The company offers comprehensive imaging solutions including preclinical imaging, radiochemistry, and data analysis. Scientific knowledge and experience, responsiveness, integrity, trust, teamwork, and dedication to strong and enduring Sponsor relationships are the defining attributes that characterize MPI Research as a high-performance, high-quality organization that is committed to bringing safer and more effective products to the world.